Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord derived mesenchymal stem cells delivered intravenously for the treatment of Polycystic Ovary Syndrome.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-16.
Trial Details
NCT Number NCT06143527
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Polycystic Ovary Syndrome (PCOS), Polycystic Ovary Syndrome, PCOS
Enrollment 20 participants
Start Date 2023-11-16
Primary Completion 2027-11-16 (estimated)
Study Completion 2027-11-16 (estimated)
Updated on ClinicalTrials.gov 2025-04-08